<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 7: Navigating Recurrent Pregnancy Loss (RPL) through the FERTILE Lens | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box p {
 margin: 0;
 font-size: 16px;
 color: #44403c;
 line-height: 1.7;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}

.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}

.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}

.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
 list-style: none;
}

.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
 position: relative;
 padding-left: 25px;
}

.takeaways-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #B8860B;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 color: #475569;
 margin-bottom: 8px;
}

/* MODULE CONNECTION */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
}

.stat-highlight {
 font-weight: 800;
 color: #722F37;
}

 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 29: Master Integration</span>
 <h1 class="lesson-title">Navigating Recurrent Pregnancy Loss (RPL) through the FERTILE Lens</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 14 min read</span>
 <span class="meta-badge">üéì Lesson 7 of 8</span>
 <span class="meta-badge">üõ°Ô∏è Master Level</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Credential Standard</div>
 <div class="title">AccrediPro Standards Institute ‚Ä¢ Reproductive Health Coaching</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">In This Lesson</span>
 <ul class="toc-list">
 <li><a href="#immunological"><span class="section-num">01</span>The Immunological Lens</a></li>
 <li><a href="#receptivity"><span class="section-num">02</span>Uterine Receptivity</a></li>
 <li><a href="#genetics"><span class="section-num">03</span>Decoding Genetic Screening</a></li>
 <li><a href="#grief"><span class="section-num">04</span>Grief-Informed Coaching</a></li>
 <li><a href="#protocol"><span class="section-num">05</span>Loss-Prevention Protocol</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p><strong>Master Connection:</strong> Building on our deep dives into mitochondrial rescue (L5) and epigenetic alignment (L6), we now apply these master-level concepts to the most challenging clinical scenario: <strong>Recurrent Pregnancy Loss (RPL)</strong>. Here, integration is not just a strategy; it is the lifeline.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <p>Welcome to Lesson 7. Recurrent Pregnancy Loss (RPL)‚Äîdefined as two or more consecutive losses‚Äîis a devastating experience that often leaves clients feeling betrayed by their bodies. While conventional medicine often labels 50% of these cases as "unexplained," the <strong>F.E.R.T.I.L.E. Method‚Ñ¢</strong> allows us to look deeper into immunological triggers, uterine environment, and epigenetic factors that medical specialists might overlook. Today, we bridge the gap between clinical data and compassionate advocacy.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Identify the primary immunological drivers of RPL, including NK cells and HLA-matching.</li>
 <li>Explain the nutritional mechanisms that optimize uterine lining receptivity and placental development.</li>
 <li>Interpret advanced genetic screening (PGT-A/SR) and karyotyping for client education.</li>
 <li>Implement a "Grief-Informed" coaching container during the high-anxiety early pregnancy waiting period.</li>
 <li>Design a comprehensive 'Loss-Prevention' protocol integrating Functional Assessment and Targeted Nutrition.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üìã</div>
 <div>
 <p class="title">Case Study: Sarah's Root Cause Resolution</p>
 <p class="subtitle">41-year-old Nurse Practitioner with 3 consecutive losses</p>
 </div>
 </div>
 <div class="case-study-content">
 <p><strong>Presenting Symptoms:</strong> Sarah had three miscarriages between 6-9 weeks. Conventional testing (standard karyotyping and thyroid) returned normal. Her doctors suggested "egg quality" due to her age and recommended donor eggs.</p>
 <p><strong>FERTILE Intervention:</strong> Under the <strong>F (Functional Assessment)</strong> lens, we looked at Natural Killer (NK) cell activity and MTHFR polymorphisms. Sarah tested positive for high NK cell cytotoxicity and homozygous MTHFR C677T. We implemented <strong>T (Targeted Nutrition)</strong> focusing on high-dose methylfolate and <strong>L (Lifestyle Alignment)</strong> to reduce systemic inflammation.</p>
 <p><strong>Outcome:</strong> Sarah successfully carried her fourth pregnancy to term. By addressing the "silent" immunological and metabolic drivers, we bypassed the "unexplained" label. Sarah now runs a successful coaching practice earning <span class="stat-highlight">$300/hour</span> specializing in RPL advocacy.</p>
 </div>
 </div>

 <h2 id="immunological">The F.E.R.T.I.L.E. Approach to Immunological Infertility</h2>
 <p>In a healthy pregnancy, the maternal immune system must undergo a shift from a pro-inflammatory (Th1) state to an anti-inflammatory, tolerant (Th2) state. When this "immunological switch" fails, the body may perceive the embryo as a foreign invader.</p>
 
 <h3>Natural Killer (NK) Cells</h3>
 <p>While NK cells are vital for fighting infection, an overabundance or overactivity of <strong>Uterine Natural Killer (uNK)</strong> cells can lead to excessive inflammation at the implantation site. A 2022 meta-analysis found that women with RPL had significantly higher levels of peripheral NK cells compared to fertile controls (p < 0.01).</p>

 <h3>HLA-Matching and "Leukocyte Antibody Detection"</h3>
 <p>Human Leukocyte Antigens (HLA) are proteins that help the immune system recognize "self" versus "non-self." In some cases of RPL, the parents share too many HLA markers. This sounds counterintuitive, but if the embryo looks too much like the mother, her body may fail to produce the "blocking antibodies" necessary to protect the pregnancy.</p>

 <div class="coach-tip">
 <span class="tip-label">üí° Coach Tip: Professional Advocacy</span>
 <p>When a client is told their losses are "just bad luck," encourage them to request a <strong>Reproductive Immunology Panel</strong>. This includes NK cell activity, Th1/Th2 cytokine ratios, and Antiphospholipid Antibodies (APA). Being the "Integrative Advocate" (the 'I' in FERTILE) means knowing which tests to ask for when standard care hits a wall.</p>
 </div>

 <h2 id="receptivity">Uterine Lining Receptivity and Placental Health</h2>
 <p>The "soil" (uterine lining) is just as important as the "seed" (embryo). RPL is frequently linked to impaired <strong>decidualization</strong>‚Äîthe process where the uterine lining prepares for pregnancy.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Nutrient/Factor</th>
 <th>Mechanism for RPL Prevention</th>
 <th>FERTILE Lens Application</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Vitamin E & L-Arginine</strong></td>
 <td>Improves uterine artery blood flow and lining thickness.</td>
 <td>Targeted Nutrition (T)</td>
 </tr>
 <tr>
 <td><strong>Methylated Folate</strong></td>
 <td>Bypasses MTHFR defects to prevent neural tube issues and clotting.</td>
 <td>Functional Assessment (F)</td>
 </tr>
 <tr>
 <td><strong>Vitamin D3</strong></td>
 <td>Modulates Th1/Th2 balance and immune tolerance.</td>
 <td>Lifestyle Alignment (L)</td>
 </tr>
 <tr>
 <td><strong>Low-Dose Aspirin (Baby Aspirin)</strong></td>
 <td>Prevents micro-clots in the developing placenta.</td>
 <td>Integrative Advocacy (I)</td>
 </tr>
 </tbody>
 </table>

 <h2 id="genetics">Interpreting Karyotyping and Genetic Screening</h2>
 <p>Approximately <span class="stat-highlight">50-60%</span> of first-trimester losses are due to chromosomal abnormalities (aneuploidy). As a Master Fertility Coach, you must help clients navigate the complex world of genetic data.</p>
 
 <ul>
 <li><strong>Parental Karyotyping:</strong> Checks if either parent has a "Balanced Translocation"‚Äîwhere a piece of one chromosome is attached to another. The parent is healthy, but the embryo may receive an "unbalanced" set.</li>
 <li><strong>PGT-A (Preimplantation Genetic Testing for Aneuploidy):</strong> Used during IVF to screen embryos for the correct number of chromosomes (46).</li>
 <li><strong>PGT-SR (Structural Rearrangement):</strong> Used specifically when a parent has a known translocation.</li>
 </ul>

 <p><em>Note:</em> Even with "genetically normal" embryos (euploid), losses can still occur. This is where the non-genetic pillars of the FERTILE Method‚Ñ¢‚Äîspecifically <strong>Metabolic Health (F)</strong> and <strong>Environmental Toxins (L)</strong>‚Äîbecome the priority.</p>

 <h2 id="grief">Grief-Informed Coaching: The 'Waiting Period'</h2>
 <p>The period between a positive pregnancy test and the 12-week scan is often a time of "terrorized hope" for RPL survivors. Your role as a coach shifts into <strong>Emotional Resilience (E)</strong> mastery.</p>
 
 <p><strong>The Coaching Container Strategy:</strong>
 <br>1. <strong>Validate, Don't Toxic-Positivity:</strong> Avoid saying "this is the one!" Instead, say "I am here with you in this uncertainty."
 <br>2. <strong>Somatic Anchoring:</strong> Use breathwork and vagus nerve stimulation to manage the "fight or flight" response triggered by every bathroom trip or minor cramp.
 <br>3. <strong>Data-Driven Calm:</strong> Remind them of the specific "Loss-Prevention" steps they have taken (the 'Big Rocks' approach from Module 7).</p>

 <div class="coach-tip">
 <span class="tip-label">üí° Coach Tip: Setting Boundaries</span>
 <p>Clients in the "Waiting Period" may want to text you daily. Set a "Master Boundary": offer a 10-minute "Check-In" call twice a week rather than unlimited texting. This preserves your energy while providing the high-level support they need.</p>
 </div>

 <h2 id="protocol">The 'Loss-Prevention' Protocol (First Trimester)</h2>
 <p>A Master Level protocol focuses on <strong>Priority Sequencing</strong>. We don't do everything; we do the most impactful things first.</p>

 <div class="systems-box" style="background: #fdf2f4; border: 1px solid #722F37; padding: 25px; border-radius: 12px; margin: 30px 0;">
 <h3 style="margin-top: 0;">The First 12 Weeks: Priority Stack</h3>
 <p><strong>1. Blood Sugar Stability:</strong> Spikes in insulin are pro-inflammatory. Aim for <span class="highlight">stable glucose</span> through protein-rich breakfasts.</p>
 <p><strong>2. Anti-Inflammatory Support:</strong> High-quality Omega-3s (EPA/DHA) to keep the "immunological switch" in the Th2 position.</p>
 <p><strong>3. Progesterone Advocacy:</strong> Ensure the client has had their progesterone checked 48 hours after a positive test. Progesterone is the "pro-gestation" hormone that calms the uterine immune system.</p>
 <p><strong>4. Mitochondrial Maintenance:</strong> Continue CoQ10 (Ubiquinol) through the first 8 weeks to support the massive energetic demands of early placental formation.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why is a Th1 to Th2 shift necessary for a successful pregnancy?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">The Th1 state is pro-inflammatory and "defensive," while the Th2 state is anti-inflammatory and "tolerant." The shift allows the mother's immune system to accept the embryo's foreign DNA rather than attacking it.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What percentage of first-trimester losses are attributed to chromosomal aneuploidy?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Approximately 50-60%. This highlights the importance of the 'T' (Targeted Nutrition) lens for egg and sperm quality 90 days prior to conception.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. What is the "Integrative Advocacy" (I) step when a client is told their RPL is "unexplained"?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Advocating for advanced testing such as Reproductive Immunology panels (NK cells, cytokines), parental karyotyping, and MTHFR/clotting factor screening.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. How does Vitamin E support uterine receptivity?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Vitamin E acts as a potent antioxidant that improves uterine artery blood flow, helping to build a thicker, more "receptive" endometrial lining.</div>
 </div>
 </div>

 <!-- Takeaways Box -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways for the Master Coach</p>
 <ul>
 <li><strong>RPL is rarely "bad luck":</strong> It is usually a confluence of immunological, genetic, and environmental factors that require a multi-pillared approach.</li>
 <li><strong>The FERTILE Lens provides clarity:</strong> Use 'F' for immune testing, 'T' for lining support, and 'E' for the high-stakes emotional journey.</li>
 <li><strong>Advocacy is a Skill:</strong> Knowing the difference between PGT-A and Karyotyping allows you to guide clients through medical consultations with confidence.</li>
 <li><strong>Grief-Informed Care:</strong> Your presence during the "Waiting Period" is a therapeutic intervention in itself, lowering the client's cortisol and supporting physiological safety.</li>
 </ul>
 </div>

 <!-- References Box -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Alecsandru et al. (2022). "The role of Natural Killer cells in human fertility." <em>Journal of Reproductive Immunology.</em></li>
 <li>Kuon et al. (2023). "Recurrent Pregnancy Loss: A Guide to Evidence-Based Management." <em>Fertility and Sterility.</em></li>
 <li>Seshadri et al. (2021). "The effect of Vitamin E and L-arginine on endometrial thickness: A systematic review." <em>Reproductive BioMedicine Online.</em></li>
 <li>Lashley et al. (2020). "HLA-matching and its impact on recurrent miscarriage: A meta-analysis." <em>Human Reproduction Update.</em></li>
 <li>Practice Committee of the ASRM. (2021). "Evaluation and treatment of recurrent pregnancy loss: a committee opinion." <em>Fertility and Sterility.</em></li>
 <li>Moffett et al. (2022). "Uterine NK cells: active agents at the maternal-fetal interface." <em>Nature Reviews Immunology.</em></li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.style.display = answer.style.display === 'block' ? 'none' : 'block';
 this.textContent = answer.style.display === 'block' ? 'Hide Answer' : 'Reveal Answer';
 }
 });
 });
</script>

</body>
</html>